About Nymox Pharmaceutical Drug Fexapotide for the Prevention of Prostate Cancer

Benign Prostate Hypertrophy (BPH)
Is Fexapotide the Safest and Effective Prostate Cancer Preventative?
That’s what Nymox Pharmaceutical (NYMX) announced in its recent press release stating that results from from 7-year prospective placebo controlled double blind studies of treatment of 995 U.S. men with its lead drug fexapotide were positive.

According to the press release, men who received fexapotide showed a major reduction in the incidence of prostate cancer, compared to placebo and compared to the known and expected normal incidence of the disease. The men are enrolled at over . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.